Stagg Robert
SVP, Clinical R&D at OncoMed Pharmaceuticals Inc
- Sold, on record
- $16k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Oct 10, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- OncoMed Pharmaceuticals IncSVP, Clinical R&D
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale OncoMed Pharmaceuticals IncPlan not statedApr 24, 2018 2018
Sold 4,051 shares at $2.68 ($11k)
Stagg Robert, SVP, Clinical R&D
Sold 8.6% of holdings ($127k position)43,283 shares leftFirst sale on recordFiling
- 2 Form 4 sale OncoMed Pharmaceuticals IncPlan not statedOct 9, 2018 +168 days
Sold 1,686 shares at $2.13 ($4k)
Stagg Robert, SVP, Clinical R&D
Sold 3.9% of holdings ($92k position)41,597 shares leftFiling
- 3 Form 4 sale OncoMed Pharmaceuticals IncPlan not statedOct 10, 2018 +1 day
Sold 927 shares at $2.01 ($2k)
Stagg Robert, SVP, Clinical R&D
Sold 2.2% of holdings ($84k position)40,670 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 10, 2018 | Oct 11, 2018 | OncoMed Pharmaceuticals Inc | SVP, Clinical R&D | Form 4 sale | 927 | $2k | 2.2% | Plan not stated | SEC |
| Oct 9, 2018 | Oct 10, 2018 | OncoMed Pharmaceuticals Inc | SVP, Clinical R&D | Form 4 sale | 1,686 | $4k | 3.9% | Plan not stated | SEC |
| Apr 24, 2018 | Apr 26, 2018 | OncoMed Pharmaceuticals Inc | SVP, Clinical R&D | Form 4 sale | 4,051 | $11k | 8.6% | Plan not stated | SEC |